Berkeley, California
United States
22
2026-05-28
The entities that hold a legal rights for patent applications filed by inventor MILES Dillon Harding:
Dillon Harding MILES from Berkeley, US has applied for patents for these inventions. The list has both pending applications and granted patents:
MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF
#2 | 2025-10-16INHIBITORS OF ADENOSINE 5'-NUCLEOTIDASE
#3 | 2025-07-17SALT FORMS OF AN AXL INHIBITOR
#4 | 2024-12-26Compounds as inhibitors of AXL
#5 | 2024-10-24MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF
#6 | 2024-08-29Inhibitors of adenosine 5′-nucleotidase
#7 | 2024-07-25AXL COMPOUNDS
#8 | 2024-07-11AXL INHIBITOR COMPOUNDS
#9 | 2023-12-28COMPOUNDS AS INHIBITORS OF AXL
#10 | 2023-01-262,3,5-TRISUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS
#11 | 2022-07-28PROCESSES FOR PREPARING AMINOPYRIMIDINE COMPOUNDS
#12 | 2022-03-03Solid forms of a CD73 inhibitor and the use thereof
#13 | 2021-12-02Modulators of 5′-nucleotidase, ecto and the use thereof
#14 | 2021-09-02Solid forms of an azolopyrimidine compound
#15 | 2021-07-15Quinazoline-pyrazole derivatives for the treatment of cancer-related disorders
#16 | 2021-06-03Pyridone A2R antagonists
#17 | 2021-01-07Modulators of 5′-nucleotidase, ecto and the use thereof
#18 | 2020-07-16Inhibitors of adenosine 5′-nucleotidase
#19 | 2020-03-05Quinazoline-pyridine derivatives for the treatment of cancer-related disorders
#20 | 2020-02-27Inhibitors of CD73-mediated immunosuppression
#21 | 2019-10-10Modulators of 5′-nucleotidase, ecto and the use thereof
#22 | 2017-09-21Modulators of 5′-nucleotidase, ecto and the use thereof
1987973 ⎘